Taiwan · Delayed Price · Currency is TWD BIONET Therapeutics Statistics
Total Valuation
TPEX:7808 has a market cap or net worth of TWD 2.26 billion. The enterprise value is 1.26 billion.
| Market Cap | 2.26B |
| Enterprise Value | 1.26B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:7808 has 70.00 million shares outstanding. The number of shares has increased by 3.39% in one year.
| Current Share Class | 70.00M |
| Shares Outstanding | 70.00M |
| Shares Change (YoY) | +3.39% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.89% |
| Owned by Institutions (%) | 1.91% |
| Float | 35.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.52 |
| PB Ratio | 1.90 |
| P/TBV Ratio | 1.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.75, with a Debt / Equity ratio of 0.02.
| Current Ratio | 16.75 |
| Quick Ratio | 15.98 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.26 |
| Interest Coverage | -276.02 |
Financial Efficiency
Return on equity (ROE) is -6.87% and return on invested capital (ROIC) is -5.18%.
| Return on Equity (ROE) | -6.87% |
| Return on Assets (ROA) | -4.98% |
| Return on Invested Capital (ROIC) | -5.18% |
| Return on Capital Employed (ROCE) | -8.48% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 105 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 2.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.69% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -36.69% |
| 50-Day Moving Average | 31.87 |
| 200-Day Moving Average | 45.01 |
| Relative Strength Index (RSI) | 49.55 |
| Average Volume (20 Days) | 13,149 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:7808 had revenue of TWD 196.63 million and -84.09 million in losses. Loss per share was -1.20.
| Revenue | 196.63M |
| Gross Profit | 99.10M |
| Operating Income | -102.68M |
| Pretax Income | -84.09M |
| Net Income | -84.09M |
| EBITDA | -84.47M |
| EBIT | -102.68M |
| Loss Per Share | -1.20 |
Balance Sheet
The company has 1.03 billion in cash and 23.95 million in debt, with a net cash position of 1.01 billion or 14.39 per share.
| Cash & Cash Equivalents | 1.03B |
| Total Debt | 23.95M |
| Net Cash | 1.01B |
| Net Cash Per Share | 14.39 |
| Equity (Book Value) | 1.19B |
| Book Value Per Share | 17.04 |
| Working Capital | 1.06B |
Cash Flow
In the last 12 months, operating cash flow was -38.46 million and capital expenditures -52.33 million, giving a free cash flow of -90.79 million.
| Operating Cash Flow | -38.46M |
| Capital Expenditures | -52.33M |
| Depreciation & Amortization | 19.93M |
| Net Borrowing | -2.25M |
| Free Cash Flow | -90.79M |
| FCF Per Share | -1.30 |
Margins
Gross margin is 50.40%, with operating and profit margins of -52.22% and -42.77%.
| Gross Margin | 50.40% |
| Operating Margin | -52.22% |
| Pretax Margin | -42.77% |
| Profit Margin | -42.77% |
| EBITDA Margin | -42.96% |
| EBIT Margin | -52.22% |
| FCF Margin | n/a |
Dividends & Yields
TPEX:7808 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.39% |
| Shareholder Yield | -3.39% |
| Earnings Yield | -3.71% |
| FCF Yield | -4.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:7808 has an Altman Z-Score of 25.28 and a Piotroski F-Score of 3.
| Altman Z-Score | 25.28 |
| Piotroski F-Score | 3 |